I think people need to turn those tunnel vision glasses off.
They create too much stress.
I know we all dream about big profits etc, (even I do )but first and that's what Wayne and Co are doing at the moment and I think it would appear they have a pretty good grasp as to what's needed.
Put the right foundations in and build it right first time and create products that are best in class.
We need to remember that we're up against the best (who are far bigger in size and money than us) and show the surgeons we don't only make things, but things that are superior to other products presently available in the market place.
There's a number of things happening at the present time that are potential BIG earners.
Just re-read this piece from the latest 4C :-
------------------
The Company recently announced that we submitted IP applications for our pioneering new Transcatheter Aortic Valve Replacement (TAVR) device. The two patent pending applications in the United States relate to the development and manufacture of a three-dimensional replacement heart valve using Admedus’ clinically superior proprietary ADAPT® technology that requires minimal suturing and a hydro-packaging system that will revolutionise the way TAVR products are assembled and distributed. This marks the beginning of our entry into the $3B global TAVR market (projected to grow to more than $5B by 2020). We entered an exclusive supply agreement with 4C Medical Technologies, Inc., providing access to a potentially significant new revenue stream. Under the agreement, 4C Medical will utilise ADAPT®-engineered tissue for the functioning leaflet component of their novel designed Transcatheter Mitral Valve Replacement (TMVR) technology. With millions suffering from mitral regurgitation, the market for these devices is expected to reach more than $3B by 2022. Early in the quarter, we announced that CardioCel® 3D was moving from a pre-market programme to an expanded access programme: broadening the number of reference centres from four to ten as we introduce the product in a phased and prudent way working closely with physicians
-------------------------------------------------
There is quite a bit going on in the peripherals, that has the potential to make massive profits, plus there is more to follow,once they have embedded these latest products in.
The company is working closely with surgeons, supplying a rep to be present during early 3D operations to make sure they get any help they need, so they have the best possible experience with this new product on the block, which we like to think is superior to what else is on offer.
They mentioned, when talking with surgeons earlier, about 3D, that 85% said if the product does what they expect that they would want to use it.
Since doing initial operations with these products, the surgeons have been impressed enough to say that they would look at using other Cardiol Cel ADAPT products as well.
Spend the time with these fuzzy, pedantic and sometimes a little eccentric surgeons and make sure they have a great experience and you can quite often make a friend.
At the end of the day they want to do the best for their patients.
In AHZ's case, the opportunity to make some real $$$$$.
With what we've seen since Wayne has been on board (and Wayne doesn't have the word 'fail,' in his vocabulary ) is AHZ been built from the ground up.
He didn't say it was going to be tomorrow, but expects to see the real fruits start to really start to happen in about 12 months.
With what happening at the present time, it definitely is looking very exciting for AHZ in the coming months.
If I was PFG, I don't think I would be lending money to AHZ unless I thought they could do what they said they could.
IMO
Regards
Dabru
Expand
(20min delay)